Vitrafy Life Sciences Ltd (VFY.AX) stock: key figures, P/E, revenue and dividend
Information Technology · Australia
Vitrafy Life Sciences Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 65,112.00 AUD | 168,726.00 AUD |
| Gross profit | 65,112.00 AUD | 168,726.00 AUD |
| Operating income | -16.57 m AUD | -20.44 m AUD |
| EBIT | -26.22 m AUD | -16.17 m AUD |
| Net income | -32.71 m AUD | -16.17 m AUD |
| Diluted EPS – continuing operations | -0.51 AUD | -0.21 AUD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Vitrafy Life Sciences Ltd
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. It offers cryopreservation medical devices, including freezers, thawers, and packaging solutions. The company also provides the LifeChain software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials, as well as the Guardion, non-medical hardware device. Its cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
More stocks
- HansBiomed Corporation (042520.KQ)
- Hanpin Electron Co Ltd (2488.TW)
- Tonlin Department Store Co Ltd (2910.TW)
- AOPEN Inc (3046.TW)
- OnKure Therapeutics, Inc. (OKUR)
- Aurona Industries (8074.TWO)
- Apyx Medical Corp (APYX)
- Silitech Technology Corp (3311.TW)
- Emro Inc. (058970.KQ)
- Arbor Technology (3594.TWO)
- Uniplus Electronics Co Ltd (5381.TWO)
- Daios Plastics S.A. (DAIOS.AT)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.